Key statistics
On Thursday, Charles River Laboratories International Inc (CRL:NYQ) closed at 209.62, 29.68% above the 52 week low of 161.65 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 212.29 |
---|---|
High | 213.61 |
Low | 208.78 |
Bid | 209.86 |
Offer | 239.52 |
Previous close | 206.10 |
Average volume | 586.95k |
---|---|
Shares outstanding | 51.63m |
Free float | 51.15m |
P/E (TTM) | 24.62 |
Market cap | 10.64bn USD |
EPS (TTM) | 8.37 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
- Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
- Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
- Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
- Charles River Laboratories Announces Second-Quarter 2024 Results
- Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
- Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
- Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
- Charles River to Perform Plasmid Manufacturing for AAVantgarde
- Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
More ▼